Page last updated: 2024-11-05

ethyl chloroformate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID10928
CHEMBL ID3183406
SCHEMBL ID342
MeSH IDM0050995

Synonyms (102)

Synonym
formic acid, chloro-, ethyl ester
carbonochloridic acid, ethyl ester
ethyl chlorocarbonate
541-41-3
ethyl chloroformate
hsdb 409
clhorameisensaeureaethylester [german]
ethoxycarbonyl chloride
etil cloroformiato [italian]
ethyl chloromethanoate
ai3-19852
chlorameisensaeureaethylester [german]
ECF ,
ethyle, chloroformiat d' [french]
un1182
chlorocarbonate d'ethyle [french]
brn 0385653
ethyl carbonochloridate
cloroformiato de etilo [spanish]
ethylchloorformiaat [dutch]
chloroformic acid ethyl ester
etil clorocarbonato [italian]
ethylester kyseliny chlormravenci [czech]
tl 423
chlorocarbonic acid ethyl ester
einecs 208-778-5
cathyl chloride
rifgwpkjugcatf-uhfffaoysa-
inchi=1/c3h5clo2/c1-2-6-3(4)5/h2h2,1h3
ethyl chloroformate, 97%
AKOS000119319
NCGC00248902-01
ethylchloroformate
dtxcid707186
NCGC00258587-01
dtxsid1027186 ,
cas-541-41-3
tox21_201034
BBL011487
STL146599
ethylchloorformiaat
etil cloroformiato
09601ezp9r ,
ethyle, chloroformiat d'
ethyl chloroformate [un1182] [poison]
unii-09601ezp9r
cloroformiato de etilo
etil clorocarbonato
ethylester kyseliny chlormravenci
chlorocarbonate d'ethyle
chlorameisensaeureaethylester
ec 208-778-5
clhorameisensaeureaethylester
chloro(ethoxy)methanone
SCHEMBL342
ethyl chloroformate [mi]
ethyl chloroformate [hsdb]
ethylchlorocarbonate
ethylchorocarbonate
ethylchlorocarbanate
ethyl chloroformic acid
ethyl chloro-formate
ethyl cloroformate
ethyl-carbonochloridate
chloroformic acid ethylester
clcooc2h5
ethyl chioroformate
clco2et
ethyl choroformate
ethylcloroformate
chloroformic ethyl ester
clco2ch2ch3
ethyl chlorcarbonate
ch3ch2ococl
ethyl chloroform ate
ethyl chlorformate
ethvl chloroformate
ethoxy carbonyl chloride
ethyl carbonchloridate
ethyl chloroforrnate
ethyl chloro-carbonate
ethyl chlorocarbonic acid
etoc(o)cl
carboethoxy chloride
etococl
ethyl-chloro-formate
ethoxycarbonylchloride
ethyl chloridocarbonate
clco2c2h5
clcooet
c2h5ococl
chlorocarbonic acid, ethyl ester
un 1182
chloroformic acid, ethyl ester
ethyl chloridocarbonate #
CHEMBL3183406
mfcd00000644
F2190-0128
ethyl chloroformate, purum, >=98.0% (gc)
Q288339
VS-02959
EN300-19001

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"N-ethoxycarbonylation was combined with (S)-1-phenylethylamidation for enantioseparation of amino acids by gas chromatography (GC) and gas chromatography-mass spectrometry (GC-MS) on achiral capillary columns."( N-ethoxycarbonylation combined with (S)-1-phenylethylamidation for enantioseparation of amino acids by achiral gas chromatography and gas chromatography-mass spectrometry.
Kim, KR; Lee, J; Paik, MJ, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" To avoid possible interference from stereochemical impurities, male Sprague-Dawley rats were dosed intraperitoneally with the S enantiomer (100 mg/kg) of each drug and the R enantiomer of etodolac."( Limited extent of stereochemical conversion of chiral non-steroidal anti-inflammatory drugs induced by derivatization methods employing ethyl chloroformate.
Jamali, F; Wright, MR, 1993
)
0.49
" The method was applied to quantify free and total dopamine levels in human plasma after dosing with the anti-Parkinson's drug combination L-dopa/carbidopa with and without entacapone."( Quantitative determination of free and total dopamine in human plasma by LC-MS/MS: the importance of sample preparation.
Hendriks, G; Imbos, R; Nikkanen, H; Rouru, J; Tuunainen, J; van de Merbel, NC, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency15.10300.002541.796015,848.9004AID1347399
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency2.74600.003041.611522,387.1992AID1159555
thyroid stimulating hormone receptorHomo sapiens (human)Potency1.29930.001628.015177.1139AID1259385
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (22.22)18.7374
1990's7 (12.96)18.2507
2000's12 (22.22)29.6817
2010's19 (35.19)24.3611
2020's4 (7.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.32 (24.57)
Research Supply Index4.08 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index89.52 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (56.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.75%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (1.75%)4.05%
Observational0 (0.00%)0.25%
Other55 (96.49%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]